| Borrowings |
Schedule
of borrowings
| | |
| | |
| | |
June 30, | |
| | |
December 31, | | |
December 31, | | |
2025 | |
| | |
2025 | | |
2025 | | |
(Audited) | |
| | |
US$ | | |
S$ | | |
S$ | |
| | |
| | |
| | |
| |
| Current: | |
| | | |
| | | |
| | |
| - Bank overdraft | |
| 7,682 | | |
| 9,878 | | |
| 61,371 | |
| - Lease liabilities | |
| 1,570,074 | | |
| 2,018,958 | | |
| 2,059,748 | |
| - Bank borrowings | |
| 711,982 | | |
| 915,538 | | |
| - | |
| Borrowings Current | |
| 2,289,738 | | |
| 2,944,374 | | |
| 2,121,119 | |
| | |
| | | |
| | | |
| | |
| Non-current: | |
| | | |
| | | |
| | |
| - Lease liabilities | |
| 3,132,055 | | |
| 4,027,510 | | |
| 2,956,727 | |
| - Bank borrowings | |
| 1,564,621 | | |
| 2,011,946 | | |
| - | |
| Borrowings Non-Current | |
| 4,696,676 | | |
| 6,039,456 | | |
| 2,956,727 | |
| Borrowings | |
| 6,986,414 | | |
| 8,983,830 | | |
| 5,077,846 | |
The
breakdown of borrowings are as follows:
Schedule
of breakdown borrowings
| | |
| | |
| | |
June 30, | |
| | |
December 31, | | |
December 31, | | |
2025 | |
| | |
2025 | | |
2025 | | |
(Audited) | |
| | |
US$ | | |
S$ | | |
S$ | |
| | |
| | |
| | |
| |
| Term loan
#1 | |
| 2,276,603 | | |
| 2,927,484 | | |
| - | |
| Term
loan | |
| 2,276,603 | | |
| 2,927,484 | | |
| - | |
Basel
Medical Group Ltd and its Subsidiaries
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
For
the financial period ended December 31, 2025
| 15. |
Borrowings
(Continued) |
The
details of borrowings are as follows:
Schedule
of details borrowings
| Term loan | |
Facility
amount | | |
Effective
interest rate | |
Maturity
date |
| | |
| | |
% p.a. | |
|
| | |
| | | |
| |
|
| Term loan #1 | |
S$ | 3,000,000 | | |
Prime Rate + 4% | |
November 2028 |
| Term loan | |
Facility
amount | | |
Effective
interest rate | | |
Maturity
date |
| | |
| | |
% p.a. | | |
|
| | |
| | | |
| | | |
|
| Term loan #13 | |
S$ | 3,000,000 | | |
| 9 | % | |
November 2028 |
The
Group obtained a term loan facility from Green Link Digital Bank for working capital purposes. The loan bears interest at a floating
rate and is repayable by monthly instalments over a period of three years. The facility is secured by corporate guarantees from related
companies, a fixed deposit pledged with the bank, and charges over the Group’s bank accounts. The carrying amount of the loan as
at the reporting date was S$2,927,484 (US$2,276,603) (June 30, 2025: S$Nil).
Basel
Medical Group Ltd and its Subsidiaries
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
For
the financial period ended December 31, 2025
| 15. |
Borrowings
(Continued) |
A
reconciliation of liabilities arising from financing activities is as follows:
Schedule
of reconciliation of liabilities arising from financing activities
| | |
Beginning
| | |
| | |
Proceed | | |
Non-cash
changes | | |
| | |
| |
| | |
of
financial | | |
Cash | | |
from
bank | | |
| | |
Accretion
of | | |
| | |
Fair value | | |
End of financial | |
| | |
year | | |
flows | | |
borrowings | | |
Addition | | |
interests | | |
Other | | |
reserve | | |
year | |
| | |
US$ | | |
US$ | | |
US$ | | |
US$ | | |
US$ | | |
US$ | | |
US$ | | |
US$ | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| December 31, 2025 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Liabilities | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Bank overdraft | |
| 47,726 | | |
| (40,044 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 7,682 | |
| Lease liabilities | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| - Current | |
| 1,601,795 | | |
| (1,433,280 | ) | |
| - | | |
| 1,442,808 | | |
| 91,093 | | |
| - | | |
| - | | |
| 1,702,416 | |
| - Non-current | |
| 2,299,344 | | |
| - | | |
| - | | |
| 700,369 | | |
| - | | |
| - | | |
| - | | |
| 2,999,713 | |
| Bank borrowings | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| - Current | |
| - | | |
| (74,567 | ) | |
| 768,375 | | |
| - | | |
| 18,174 | | |
| - | | |
| - | | |
| 711,982 | |
| - Non-current | |
| - | | |
| - | | |
| 1,564,621 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,564,621 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | |
| 3,948,865 | | |
| (1,547,891 | ) | |
| 2,332,996 | | |
| 2,143,177 | | |
| 109,267 | | |
| - | | |
| - | | |
| 6,986,414 | |
Basel
Medical Group Ltd and its Subsidiaries
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
For
the financial period ended December 31, 2025
| 15. |
Borrowings
(Continued) |
| | |
Beginning | | |
| | |
Proceed | | |
Non-cash
changes | | |
| | |
| |
| | |
of
financial | | |
Cash | | |
from
bank | | |
| | |
Accretion
of | | |
| | |
Fair
value | | |
End
of financial | |
| | |
year | | |
flows | | |
borrowings | | |
Addition | | |
interests | | |
Other | | |
reserve | | |
year | |
| | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| December
31, 2025 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Liabilities | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Bank
overdraft | |
| 61,371 | | |
| (51,493 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 9,878 | |
| Lease
liabilities | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| -
Current | |
| 2,059,748 | | |
| (1,843,055 | ) | |
| - | | |
| 1,855,307 | | |
| 117,136 | | |
| - | | |
| - | | |
| 2,189,136 | |
| -
Non-current | |
| 2,956,727 | | |
| - | | |
| - | | |
| 900,605 | | |
| - | | |
| - | | |
| - | | |
| 3,857,332 | |
| Bank
borrowings | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| -
Current | |
| - | | |
| (95,886 | ) | |
| 988,054 | | |
| - | | |
| 23,370 | | |
| - | | |
| - | | |
| 915,538 | |
| -
Non-current | |
| - | | |
| - | | |
| 2,011,946 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 2,011,946 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | |
| 5,077,846 | | |
| (1,990,434 | ) | |
| 3,000,000 | | |
| 2,755,912 | | |
| 140,506 | | |
| - | | |
| - | | |
| 8,983,830 | |
Basel
Medical Group Ltd and its Subsidiaries
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
For
the financial period ended December 31, 2025
| 15. |
Borrowings
(Continued) |
| | |
Beginning | | |
| | |
Proceed | | |
Non-cash
changes | | |
| | |
| |
| | |
of financial | | |
Cash | | |
from bank | | |
| | |
Accretion
of | | |
| | |
Fair value | | |
End of financial | |
| | |
year | | |
flows | | |
borrowings | | |
Addition | | |
interests | | |
Other | | |
reserve | | |
year | |
| | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| June 30, 2025 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Liabilities | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Bank overdraft | |
| - | | |
| - | | |
| 61,371 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 61,371 | |
| Lease liabilities | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| - Current | |
| 28,500 | | |
| (1,096,308 | ) | |
| - | | |
| 4,524,209 | | |
| 114,966 | | |
| (1,511,619 | ) | |
| - | | |
| 2,059,748 | |
| - Non-current | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 50,087 | | |
| 2,906,640 | | |
| 2,956,727 | |
| Bank borrowings | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| - Current | |
| 2,677,856 | | |
| (6,766,838 | ) | |
| 4,000,000 | | |
| - | | |
| 88,982 | | |
| - | | |
| - | | |
| - | |
| - Non-current | |
| 1,583,434 | | |
| (1,583,434 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | |
| 4,289,790 | | |
| (9,446,580 | ) | |
| 4,061,371 | | |
| 4,524,209 | | |
| 203,948 | | |
| (1,461,532 | ) | |
| 2,906,640 | | |
| 5,077,846 | |
Basel
Medical Group Ltd and its Subsidiaries
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
For
the financial period ended December 31, 2025
|